Clincosm LogoSign in Get a demo

fallopian tube neoplasms

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)

Not yet recruiting
  • Ovarian Cancer
  • +5 more
  • MIRRORS Protocol
  • Standard Open Cytoreductive Surgery
  • (no location specified)
Jul 17, 2023

Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • +8 more
  • AB-1015
  • Iowa City, Iowa
    U. of Iowa Health Care
Jan 30, 2023

Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Worldwide (biological, drug, other)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pembrolizumab
  • +4 more
  • Phoenix, Arizona
  • +178 more
Jan 25, 2023

Ovarian Tumor Epithelial, Ovarian Cancer, Fallopian Tube Tumors Trial in India (Oregovomab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Ovarian Neoplasm Epithelial
  • +4 more
  • Oregovomab
  • +3 more
  • Visakhapatnam, Andhra Pradesh, India
  • +7 more
Dec 7, 2022

Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in United States (SGN-B7H4V)

Recruiting
  • Ovarian Neoplasms
  • +9 more
  • Aurora, Colorado
  • +6 more
Aug 15, 2022

Genital Diseases, Female, Ovarian Diseases, Ovarian Tumors Trial in Worldwide (biological, drug, other)

Completed
  • Genital Diseases, Female
  • +4 more
  • Bevacizumab
  • +3 more
  • Aalborg, Denmark
  • +130 more
Jul 19, 2022

Solid Tumor, Adult, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Houston (BP1001-A (Liposomal Grb2 Antisense

Not yet recruiting
  • Solid Tumor, Adult
  • +5 more
  • BP1001-A (Liposomal Grb2 Antisense Oligonucleotide)
  • BP1001-A (Liposomal Grb2 Antisense Oligonucleotide) with paclitaxel
  • (no location specified)
Jun 7, 2022

Developing a Test for the Detection of Ovarian Cancer

Recruiting
  • Ovarian Neoplasms
  • +14 more
  • Uterine lavage, or a wash of the womb
  • +2 more
  • Little Rock, Arkansas
  • +5 more
Apr 29, 2022

Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in India (Bevacizumab)

Recruiting
  • Ovarian Neoplasms
  • +2 more
  • Vijayawada, Andhra Pradesh, India
  • +24 more
Apr 1, 2022

Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors, Peritoneal Tumors Trial in Montpellier (Biological collection)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • +2 more
  • Biological collection
  • Montpellier, France
    ICM - Institut régional du Cancer Montpellier
Mar 11, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinosarcoma Trial in Germany, United Kingdom (Paclitaxel, TAK228)

Active, not recruiting
  • Ovarian Cancer
  • +9 more
  • Berlin, Germany
  • +14 more
Mar 10, 2022

Ovarian Tumors, Fallopian Tube Tumors, Tumors by Site Trial (Drug: Anlotinib, Drug: Carboplatin/Paclitaxel)

Not yet recruiting
  • Ovarian Neoplasms
  • +14 more
  • Drug: Anlotinib
  • Drug: Carboplatin/Paclitaxel
  • (no location specified)
Mar 17, 2021

Cancer Diagnosis and Treatment on Everyday Life

Active, not recruiting
  • Breast Cancer Female
  • +17 more
    • Aberystwyth, United Kingdom
    • +110 more
    Mar 16, 2021

    Compare Fallopian Tube Cells Collected by Cytuity With Removed

    Completed
    Has Results
    • Fallopian Tube Cancer
    • +10 more
    • Hysteroscopic cell sampling of the fallopian tube
    • San Diego, California
    • +9 more
    Dec 30, 2020

    Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)

    Unknown status
    • Ovarian Neoplasms
    • +23 more
    • Nanjing, Jiangsu, China
      JiangSu Cancer Hospital
    Nov 8, 2020

    Ovarian Cancer, Fallopian Tube Tumors, Peritoneal Tumor Trial in Worldwide (enzastaurin, carboplatin, paclitaxel)

    Completed
    Has Results
    • Ovarian Cancer
    • +2 more
    • Leuven, Belgium
    • +14 more
    Sep 23, 2020

    Ovarian Tumors, Fallopian Tube Tumors, Peritoneal Tumors Trial in Australia, United States (Part A: Dose Escalation of

    Completed
    • Ovarian Neoplasms
    • +2 more
    • Part A: Dose Escalation of Cantrixil
    • Part B: Expansion Cohort of Cantrixil
    • Oklahoma City, Oklahoma
    • +5 more
    Apr 16, 2020

    Ovarian Tumors, Ovarian Cancer, Fallopian Tube Tumors Trial ([18F]-CP18, PET/ CT)

    Withdrawn
    • Ovarian Neoplasms
    • +3 more
    • (no location specified)
    Dec 3, 2019

    Urinary Bladder Tumors, Carcinoma, Transitional Cell, Ovarian Tumors Trial in Worldwide (CC-486, Carboplatin, ABI-007)

    Completed
    • Urinary Bladder Neoplasms
    • +7 more
    • Scottsdale, Arizona
    • +12 more
    Nov 7, 2019

    Fallopian Tube Tumors, Peritoneal Tumors, Ovarian Tumors Trial in Houston (ABI-007, Carboplatin)

    Terminated
    • Fallopian Tube Neoplasms
    • +2 more
    • Houston, Texas
      University of Texas, MD Anderson Cancer Center
    Oct 16, 2019

    Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in Worldwide (Trabectedin, DOXIL, Dexamethasone)

    Completed
    Has Results
    • Ovarian Neoplasms
    • +2 more
    • Birmingham, Alabama
    • +141 more
    Mar 29, 2019

    Uterine Cervical Tumors, Ovarian Tumors, Gynecologic Tumors Trial in Ann Arbor (Specialized Symptom Management and Supportive

    Completed
    • Uterine Cervical Neoplasms
    • +6 more
    • Specialized Symptom Management and Supportive Care
    • Ann Arbor, Michigan
      University of Michigan Comprehensive Cancer Center
    Mar 19, 2019

    Adenocarcinoma, Ovarian Tumors, Fallopian Tube Tumors Trial in Atlanta (MiCK Assay)

    Completed
    • Adenocarcinoma
    • +3 more
    • MiCK Assay
    • Atlanta, Georgia
      Southeastern Gynecologic Oncology
    Mar 9, 2018

    Epithelial Ovarian Cancer, Peritoneal Tumors, Fallopian Tube Tumors Trial run by the NCI (Birinapant (TL32711))

    Terminated
    Has Results
    • Epithelial Ovarian Cancer
    • +2 more
    • Birinapant (TL32711)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 24, 2017

    Uterine Cervical Tumors, Uterine Tumors, Ovarian Tumors Trial in Ann Arbor (Guided Imagery With Audio Media)

    Completed
    • Uterine Cervical Neoplasms
    • +4 more
    • Guided Imagery With Audio Media
    • Ann Arbor, Michigan
      University of Michigan Cancer Center
    Mar 16, 2017